Connect wallet to trade · No wallet? Passkey login available · Free alerts at /subscribe
As of mid-May 2026, measles transmission in the U.S. remains low and geographically fragmented, with the CDC confirming case counts through real-time surveillance. The market resolves YES if confirmed cases reach 2,000 by May 31—just 15 days away. With 12% odds, traders assess only a 1 in 8 chance of crossing this threshold. This probability reflects skepticism that current measles transmission could accelerate dramatically in such a narrow window. Reaching 2,000 cases would require approximately 133+ new confirmed cases per day—a pace inconsistent with recent U.S. outbreak patterns. The 2019 measles resurgence, among the largest recent outbreaks, took several months to accumulate 1,200 cases across 31 states. Current odds suggest traders view a sudden spike as unlikely without a major catalyzing event: a highly transmissible variant, a large gathering in an under-vaccinated area, or an undetected cluster surfacing in public health screening.
What factors could move this market?
Measles is among the world's most contagious viral diseases, with an R0 (reproduction number) of 12–18, meaning one infected person typically infects 12–18 others in a fully susceptible population. The United States eliminated endemic measles in 2000 through sustained high vaccination rates—the MMR (measles, mumps, rubella) vaccine provides lifelong immunity in over 97% of properly vaccinated individuals. However, measles has never been fully eradicated globally; routine importations from endemic regions abroad can rekindle U.S. transmission chains, especially in communities with vaccination coverage gaps or immune-compromised populations. The 2019 U.S. measles resurgence, driven partly by imported cases and vaccine hesitancy in tight-knit communities, eventually reached 1,282 confirmed cases across 31 states—a significant event but one that unfolded over several months, not weeks. Since 2020, vaccination coverage has generally improved in most U.S. regions, particularly in urban centers, though pockets of low immunization persist in certain religious communities, some rural regions, and school districts with elevated vaccine skepticism. Current measles transmission in the U.S. remains low and geographically fragmented as of mid-May 2026, with no sustained community spread chains detected by health authorities. For this market to resolve YES, 2,000 cases would need to be confirmed by May 31—requiring rapid escalation of an existing outbreak, simultaneous multi-region flare-ups, or emergence of a measles variant with altered transmissibility. The CDC's surveillance infrastructure is robust and standardized, making case counts objective and verifiable. Factors supporting the 88% NO probability include the low baseline of active transmission, widespread vaccination access, rapid public health response protocols (contact tracing, quarantine), and media amplification that accelerates behavioral precautions. Factors supporting YES would include discovery of a large, previously undetected cluster, a more transmissible variant, or a super-spreader event in an under-vaccinated population. The 12% odds reveal trader conviction that such escalation is improbable within 15 days. Historical analogs support this skepticism: the 2019 resurgence took approximately three months to accumulate 1,000 cases. Hitting 2,000 in two weeks would require unprecedented acceleration in modern U.S. measles epidemiology.
What are traders watching for?
CDC measles surveillance updates through late May; traders monitor for sudden cluster discovery or variant alerts near month-end.
State health department outbreak announcements; detection of a super-spreader event in under-vaccinated communities would immediately shift odds.
International measles variant detection or importation of more transmissible strain; new variant reports typically trigger swift market repricing.
Memorial Day weekend travel and gatherings (May 24-26) in under-vaccinated areas; post-holiday transmission acceleration could reshape trajectory.
How does this market resolve?
The market resolves YES if the CDC confirms 2,000 or more measles cases in the U.S. by May 31, 2026. Case counts are verified through CDC official surveillance reporting and public health databases.
Polymarket Trade is an independent third-party interface to the Polymarket CLOB prediction market exchange on Polygon — not affiliated with Polymarket, Inc. Prediction markets aggregate trader expectations into real-time probability estimates. Every market question resolves YES or NO based on a specific event outcome; traders buy shares of the side they believe will resolve positively. Prices range 0¢ (certain no) to 100¢ (certain yes) and naturally reflect the crowd-implied probability of YES. Polymarket Trade is non-custodial — your funds never leave your wallet. Open the full interactive page linked above to place orders, see order book depth, and execute a trade.
